Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) — Form 8-K: Current report
About this filing
Kyverna Therapeutics, Inc. (KYTX) filed an 8-K on Sep 24, 2026 reporting a Regulation FD disclosure (Item 7.01), with exhibits (Item 9.01).
Key facts
- Item 7.01 · Regulation FD disclosure
- Item 9.01 · Financial statements and exhibits
More KYTX filings
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- SC 13G
Filed Oct 19, 2026
- SC 13G/A
Filed Aug 14, 2026
- 10-Q
Filed Aug 11, 2026
- 8-K
Filed Aug 11, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.